Monday, February 9, 2026
ADVT 
International

Flood situation in Pak highly likely to boost disease spread: WHO

Darpan News Desk IANS, 01 Sep, 2022 11:13 AM
  • Flood situation in Pak highly likely to boost disease spread: WHO

Islamabad, Sep 1 (IANS) The catastrophic flood situation in Pakistan will highly likely increase the spread of disease, says the World Health Organization (WHO), as the country continues its relentless battle against the deadly deluges.

In its latest situation report on flooding in Pakistan, the WHO pointed out that the heavy monsoon rain which started in mid-June are continuing in many parts of the country and have affected 116 districts (75 per cent) out of the total 160, Geo News reported.

The most affected province is Sindh, followed by Balochistan.

As of August 25, more than 33 million people have been affected and over 6.4 million people are in dire need of humanitarian aid, including 421,000 refugees, the WHO report highlighted.

More than 1,100 lives have been lost and almost 15,000 people injured.

The WHO report focused on what it called the "severe" impact on health facilities, stating that as of August 28, 888 health facilities have been damaged in the country of which 180 of them are completely damaged.

Photo courtesy of IANS. 

"Access to health facilities, health care workers, and essential medicines and medical supplies remain the main health challenges for now," Geo News quoted the WHO report as saying.

Pakistan's health system is already battling multiple concurrent health threats, including Covid-19, and outbreaks of cholera, typhoid, measles, leishmaniasis and HIV, the WHO said, adding that even before the current floods, there was a significant disparity in access to health services between rural and urban areas.

Meanwhile, health experts have sounded the alarm regarding the outbreak of disease in flood-affected areas, estimating around five million people to fall sick in the next four to 12 weeks.

MORE International ARTICLES

Macy's plans smaller but camera-ready Thanksgiving parade

Macy's plans smaller but camera-ready Thanksgiving parade
Macy's similarly remade its traditional July Fourth fireworks show this year, swapping the big one-night spectacle for a series of smaller fireworks displays.

Macy's plans smaller but camera-ready Thanksgiving parade

Trump, DeVos raise school choice in appeal to vexed parents

Trump, DeVos raise school choice in appeal to vexed parents
For Trump, it’s seen as a potential lifeline to Black and Hispanic voters, who are more likely to support vouchers and other school choice options, polls have found.

Trump, DeVos raise school choice in appeal to vexed parents

Norad leaders call for 'layered defence'

Norad leaders call for 'layered defence'
Fesler and O'Shaughnessy say adversaries like Russia and China are increasingly well-positioned to exploit the "seams" that currently exist between North America's air, sea and missile defence systems and early warning networks.

Norad leaders call for 'layered defence'

Trump follows Biden to battleground Michigan

Trump follows Biden to battleground Michigan
Biden plans stiff tax penalties for companies that manufacture U.S.-bound products outside the country and a crackdown on those that use offshoring to avoid paying taxes at home.

Trump follows Biden to battleground Michigan

Biden in Michigan to talk Buy American

Biden in Michigan to talk Buy American
If elected, Biden said, he would impose stiff new tax penalties on companies that manufacture U.S.-bound products outside the country, create incentives for keeping jobs on U.S. soil and close what he called "Trump loopholes" that allow companies engaged in offshoring to avoid paying U.S. taxes.

Biden in Michigan to talk Buy American

AstraZeneca vaccine trial not going ahead due to adverse reaction in a subject

AstraZeneca vaccine trial not going ahead due to adverse reaction in a subject
A spokesperson for AstraZeneca, via a statement said that the company’s “standard review process triggered a pause to vaccination to allow review of safety data.”

AstraZeneca vaccine trial not going ahead due to adverse reaction in a subject